ArticleBMC cancer2026

Efficacy and safety of nab-paclitaxel plus PD-1 inhibitor in elderly patients with advanced squamous lung cancer.

Heya Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.